Singapore markets closed

Eloxx Pharmaceuticals, Inc. (ELOX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.8014-0.0486 (-5.72%)
At close: 02:01PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
28,342
23,727
45,569
14,590
26,349
Selling general and administrative
11,679
10,692
20,449
14,847
24,206
Total operating expenses
40,021
34,419
66,018
29,437
50,555
Operating income or loss
-40,021
-34,419
-66,018
-29,437
-50,555
Interest expense
1,824
1,949
1,259
1,409
1,616
Total other income/expenses net
-96
29
542
-4,068
225
Income before tax
-41,836
-36,065
-66,727
-34,577
-50,874
Income tax expense
-
-
-
0
0
Income from continuing operations
-41,836
-36,065
-66,727
-34,577
-50,874
Net income
-41,836
-36,065
-66,727
-34,577
-50,874
Net income available to common shareholders
-41,836
-36,065
-66,727
-34,577
-50,874
Basic EPS
-8.88
-16.65
-38.15
-34.40
-53.60
Diluted EPS
-8.88
-16.65
-38.15
-34.40
-53.60
Basic average shares
2,325
2,166
1,749
1,003
951.579
Diluted average shares
2,325
2,166
1,749
1,003
951.579